Showing results (1741-1750 of 2,236) with videos related to
Sort By:
Pageof 224
Scientific Reports|February 2, 2022
Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effectFlora Alexopoulou, Esben Matzen Bech, Søren Ljungberg Pedersen, et al.Journal of Shoulder and Elbow Surgery|October 11, 2011
Complications and survival after surgical treatment of 214 metastatic lesions of the humerusRikard Wedin, Bjarne H Hansen, Minna Laitinen, et al.Molecular Metabolism|February 2, 2021
Whole-brain activation signatures of weight-lowering drugsHenrik H Hansen, Johanna Perens, Urmas Roostalu, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2014
Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in miceCamilla H F Hansen, Line S F Andersen, Lukasz Krych, et al.Ultramicroscopy|February 13, 2023
A reference-area-free strain mapping method using precession electron diffraction dataDexin Zhao, Aniket Patel, Aaron Barbosa, et al.Scientific Reports|December 4, 2020
NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat dietMarina Sokolova, Kuan Yang, Simen H Hansen, et al.Peptides|August 20, 2018
Cardiac procholecystokinin expression during haemodynamic changes in the mammalian heartJens P Goetze, Ingrid Hunter, Nora E Zois, et al.Elife|October 26, 2018
INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signalingPhi Luong, Matija Hedl, Jie Yan, et al.Nature Communications|September 17, 2024
Frontoparietal network topology as a neural marker of musical perceptual abilitiesM Lumaca, P E Keller, G Baggio, et al.Experimental Hematology|February 5, 2022
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessmentsAnita T Simonsen, Manja Meggendorfer, Marcus H Hansen, et al.Pageof 224